Shiran Ferber
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Ronit Satchi‐FainaroGalia TiramAnat Eldar‐BoockDoron ShabatPaula OfekAnna ScomparinHemda Baabur‐CohenEinat Kisin‐Finfer
- Journals
- Journal of Visualized Experiments (2 papers)Journal of Controlled Release (2 papers)Advanced Materials (1 paper)Journal of Biomedical Materials Research Part B Applied Biomaterials (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Shiran Ferber
21 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Biomaterials 299
- Pharmaceutical Science 100
- Biomedical Engineering 416
- Immunology 194
- Oncology 180
Countries citing papers authored by Shiran Ferber
This map shows the geographic impact of Shiran Ferber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiran Ferber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiran Ferber more than expected).
Fields of papers citing papers by Shiran Ferber
This network shows the impact of papers produced by Shiran Ferber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiran Ferber. The network helps show where Shiran Ferber may publish in the future.
Co-authors
The 25 scholars most cited alongside Shiran Ferber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles Hit paper breakdown → | 2023 | 103 |
| 2 | 2021 | 15 | |
| 3 | 2020 | 15 | |
| 4 | 2019 | 39 | |
| 5 | 2018 | 46 | |
| 6 | 2018 | 24 | |
| 7 | 2017 | 79 | |
| 8 | 2016 | 34 | |
| 9 | 2016 | 66 | |
| 10 | 2015 | 49 | |
| 11 | 2015 | 62 | |
| 12 | 2014 | 49 | |
| 13 | 2014 | 41 | |
| 14 | 2014 | 6 | |
| 15 | 2014 | 23 | |
| 16 | 2014 | 2 | |
| 17 | 2014 | 1 | |
| 18 | 2013 | 65 | |
| 19 | 2012 | 27 | |
| 20 | 2011 | 242 |
About Shiran Ferber
Shiran Ferber is a scholar working on Biomaterials, Molecular Medicine, Bioengineering, Cancer Research and Modeling and Simulation, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Nanoplatforms for cancer theranostics (4 papers), MicroRNA in disease regulation (3 papers), Nanoparticle-Based Drug Delivery (3 papers), 3D Printing in Biomedical Research (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Dendrimers and Hyperbranched Polymers (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Biomaterials (299 citations), Pharmaceutical Science (100 citations), Biomedical Engineering (416 citations), Immunology (194 citations) and Oncology (180 citations). Shiran Ferber has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Ronit Satchi‐Fainaro, Galia Tiram, Anat Eldar‐Boock, Doron Shabat, Paula Ofek, Anna Scomparin, Hemda Baabur‐Cohen, Einat Kisin‐Finfer, Dina Polyak and Ela Markovsky. Their work appears in journals such as Journal of Visualized Experiments, Journal of Controlled Release, Advanced Materials, Journal of Biomedical Materials Research Part B Applied Biomaterials and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.